New HIV vaccine trial aims to spark key antibodies in infected individuals
NCT ID NCT06006546
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This early-stage study tests whether an experimental vaccine can help people with HIV produce special antibodies called VRC01, which may fight the virus more effectively. About 35 participants will receive the vaccine and temporarily pause their regular HIV medication to see if the vaccine can control the virus. The main goal is to check safety and measure immune responses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta- Ponce
Atlanta, Georgia, 30303, United States
-
BIDMC
Boston, Massachusetts, 02215, United States
-
Birmingham
Birmingham, Alabama, 35294-2170, United States
-
Columbia P&S CRS Site#30329
New York, New York, 10032, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Seattle Vaccine and Prevention CRS (Site # 30331)
Seattle, Washington, 98104, United States
-
The Hope Clinic of the Emory Vaccine Center CRS (Site #31440)
Decatur, Georgia, 30030, United States
-
University of Pittsburg
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.